Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Impact of Bioimpedance Analysis in Patients With Cardiac Implantable Electronic Devices
NCT03045822Phase 4Completed
- Sponsor
- Centre Hospitalier Universitaire de Clermont-Ferrand
- Start
- Mar 2014
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial, sponsored by Centre Hospitalier Universitaire de Clermont-Ferrand. Primary endpoint: Change in CIEDs function while and after bioimpedance analysis at 6 months. Started Mar 2014; status: completed.
Beyond the preview
Go deeper on NCT03045822.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03045822.